These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 1458761)

  • 1. Clinical pharmacokinetics of ketorolac tromethamine.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1992 Dec; 23(6):415-27. PubMed ID: 1458761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
    Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketorolac, an injectable nonnarcotic analgesic.
    Litvak KM; McEvoy GK
    Clin Pharm; 1990 Dec; 9(12):921-35. PubMed ID: 2292174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.
    Hayball PJ; Wrobel J; Tamblyn JG; Nation RL
    Br J Clin Pharmacol; 1994 Jan; 37(1):75-8. PubMed ID: 8148223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly.
    Jallad NS; Garg DC; Martinez JJ; Mroszczak EJ; Weidler DJ
    J Clin Pharmacol; 1990 Jan; 30(1):76-81. PubMed ID: 2303585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketorolac: a parenteral nonsteroidal antiinflammatory drug.
    Resman-Targoff BH
    DICP; 1990 Nov; 24(11):1098-104. PubMed ID: 2275236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
    Jung D; Mroszczak E; Bynum L
    Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketorolac: an injectable NSAID.
    DiPalma JR
    Am Fam Physician; 1991 Jan; 43(1):207-10. PubMed ID: 1986489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study of the speed of onset of analgesia following intramuscular administration of ketorolac tromethamine in comparison to intramuscular morphine and placebo.
    Rice AS; Lloyd J; Miller CG; Bullingham RE; O'sullivan GM
    Anaesthesia; 1991 Jul; 46(7):541-4. PubMed ID: 1862891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketorolac tromethamine: an oral/injectable nonsteroidal anti-inflammatory for postoperative pain control.
    Redden RJ
    J Oral Maxillofac Surg; 1992 Dec; 50(12):1310-3. PubMed ID: 1447612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
    Roy SD; Manoukian E
    J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of two oral formulations of ketorolac tromethamine: Dolac and Exodol.
    Flores-Murrieta FJ; Granados-Soto V; Castañeda-Hernández G; Herrera JE; Hong E
    Biopharm Drug Dispos; 1994 Mar; 15(2):129-36. PubMed ID: 8011965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing.
    Wischnik A; Manth SM; Lloyd J; Bullingham R; Thompson JS
    Eur J Clin Pharmacol; 1989; 36(5):521-4. PubMed ID: 2787750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of ketorolac in the management of postoperative pain.
    DeAndrade JR; Maslanka M; Maneatis T; Bynum L; Burchmore M
    Orthopedics; 1994 Feb; 17(2):157-66. PubMed ID: 8190679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketorolac tromethamine.
    Med Lett Drugs Ther; 1990 Aug; 32(825):79-81. PubMed ID: 2199809
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, double-blind evaluation of ketorolac tromethamine for postoperative analgesia in ambulatory surgery patients.
    Wong HY; Carpenter RL; Kopacz DJ; Fragen RJ; Thompson G; Maneatis TJ; Bynum LJ
    Anesthesiology; 1993 Jan; 78(1):6-14. PubMed ID: 8424573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability, central effects and pharmacokinetics of intravenous ketorolac tromethamine in volunteers.
    Lucker P; Bullingham R; Hooftman L; Lloyd J; Mroszczak E
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):409-14. PubMed ID: 7981925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
    Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
    Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain.
    Staquet MJ
    J Clin Pharmacol; 1989 Nov; 29(11):1031-6. PubMed ID: 2689472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine.
    Jung D; Mroszczak EJ; Wu A; Ling TL; Sevelius H; Bynum L
    Pharm Res; 1989 Jan; 6(1):62-5. PubMed ID: 2717521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.